可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]叶明翔,裴建明.他汀类药物的功与过:降血脂药的使用新理念[J].心脏杂志,2010,22(3):433-436.
[2]Roden DM.Cellular basis of drug-induced torsades de pointes[J].Br J Pharmacol,2008, 154(7):1502-1507.
[3]Gupta A,Lawrence AT,Krishnan K,et al.Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes[J].Am Heart J,2007,153(6):891-899.
[4]Ray WA,Chung CP,Murray KT,et al.A typical antipsychotic drugs and the risk of sudden cardiac death[J].N Engl J Med,2009,360(3):225-235.
[5]Black DM,Delmas PD,Eastell R,et al.Once-yearly zoledronic acid for Treatment of postmenopausal osteoporosis[J].N Engl J Med,2007,356(18):1809-1822.
[6]Mbaya P,Alam F,Ashim S,et al.Cardiovascular effects of high dose venlafaxine XL in patients with major depressive disorder[J].Hum Psychopharmacol,2007, 22(3):129-133.
[7]Atallah E,Durand JB,Kantarjian H,et al.Congestive heart failure:Is a rare event in patients receiving imatinib therapy[J].Blood,2007,110(4):1233-1237.
[8]Nissen SE, Wolski K.Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascujar causes[J].N Engl J Med,2007,356(24):2457-2471.